Poland· PL-100527308
Austedo
A deutetrabenazine product containing deutetrabenazyna, registered in Poland by TEVA GmbH. The same ATC class is registered in 9 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Deutetrabenazine is registered in 9 of 19 countries.
Countries holding a registration under ATC N07XX16 (deutetrabenazine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Deutetrabenazine · ATC N07XX16
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Deutetrabenazyna
- Manufacturer
- TEVA GmbH
- Country
- Poland (PL)
- ATC code
- N07XX16
- ATC class
- Deutetrabenazine
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991587352
- gtin05909991587369
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
219 interactions on record for deutetrabenazine.
Graded by severity as the source publishes them — 53 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Deutetrabenazine · interactions on record
219 records
- 53 severe
- 164 moderate
- 2 minor
Most severe, free to view
- PapaverineA03AD01severe
- MetoclopramideA03FA01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Deutetrabenazine in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAUSTEDOTeva GmbH, Ulm
- FinlandAustedoTeva GmbH
- BelgiumAustedo 42 mgTeva
- IcelandAustedoTEVA GmbH
- NetherlandsAustedo 42 mg tabletten met verlengde afgifteTeva GmbH
- SwedenAustedo 42 mg DepottablettTEVA GmbH
- IrelandAustedo 42 mg prolonged-release tabletsTEVA GmbH
- United StatesAustedoTeva Neuroscience, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Austedo
- Iceland · Austedo
- Liechtenstein · Austedo
- Norway · Austedo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4a9829c1-cce3-4333-b953-d6c32ef6ae7f GET /v1/drugs/4a9829c1-cce3-4333-b953-d6c32ef6ae7f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki o przedłużonym uwalnianiu",
"source": "urpl",
"strength": "42 mg",
"packaging": "05909991587352 ¦ Rpz ¦ EU/1/25/1956/008 ¦ 164345\n28 tabl.\n05909991587369 ¦ Rpz ¦ EU/1/25/1956/009 ¦ 164346\n84 tabl.",
"substance": "Deutetrabenazyna 42 mg",
"common_name": "Deutetrabenazyna",
"pl_product_id": "100527308",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about deutetrabenazine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.